These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1036300)

  • 21. Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme.
    Orcutt JC; Molinoff PB
    J Pharmacol Exp Ther; 1977 Sep; 202(3):590-600. PubMed ID: 894523
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of chronic treatment with histamine on catecholamine content and synthesis in rat brain, heart and adrenals.
    Mazurkiewicz-Kwilecki IM; Peters DA
    Biochem Pharmacol; 1973 Dec; 22(24):3225-35. PubMed ID: 4149088
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of mestranol on blood pressure and norepinephrine in young normotensive and genetically hypertensive rats.
    Lew GM
    Gen Pharmacol; 1978; 9(3):163-6. PubMed ID: 669247
    [No Abstract]   [Full Text] [Related]  

  • 24. Developmental toxic effects of fusaric acid in CD1 mice.
    Reddy RV; Larson CA; Brimer GE; Frappier BL; Reddy CS
    Bull Environ Contam Toxicol; 1996 Sep; 57(3):354-60. PubMed ID: 8672059
    [No Abstract]   [Full Text] [Related]  

  • 25. Urinary excretion and tissue levels of catecholamines during chronic amphetamine intoxication.
    Lewander T
    Psychopharmacologia; 1968; 13(5):394-407. PubMed ID: 5706269
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethanol and sympathetic denervation effects on rat adrenal catecholamine turnover.
    Cohen LB; Sellers EM; Sellers EA; Flattery KV
    J Pharmacol Exp Ther; 1980 Mar; 212(3):425-30. PubMed ID: 6102143
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of dopamine beta-hydroxylase by goitrin, a natural antithyroid compound.
    Zenker N; Hubbard LS; Wright J
    J Nat Prod; 1988; 51(5):862-5. PubMed ID: 2462616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal catecholamine metabolism and myocardial adrenergic receptors in streptozotocin diabetic rats.
    Bitar MS; Koulu M; Rapoport SI; Linnoila M
    Biochem Pharmacol; 1987 Apr; 36(7):1011-6. PubMed ID: 2882757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2).
    Bornstein SR; Yoshida-Hiroi M; Sotiriou S; Levine M; Hartwig HG; Nussbaum RL; Eisenhofer G
    FASEB J; 2003 Oct; 17(13):1928-30. PubMed ID: 12897061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the functional role of intraneuronal monamine oxidase.
    Clarke DE; Sampath SS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):539-49. PubMed ID: 4770399
    [No Abstract]   [Full Text] [Related]  

  • 32. Catecholamines: effects of ACTH and adrenal corticoids.
    Axelrod J
    Ann N Y Acad Sci; 1977 Oct; 297():275-83. PubMed ID: 29549
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of cardiac glycosides on indices of mediator metabolism in conditions of experimental pathology].
    Cherkes AI; Frantsuzova SB
    Biull Eksp Biol Med; 1972 Dec; 73(12):52-4. PubMed ID: 4674551
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood pressure response to ethanol in relation to acetaldehyde levels and dopamine-beta-hydroxylase activity in rats pretreated with disulfiram, cyanamide and coprine.
    Tottmar O; Hellström E
    Acta Pharmacol Toxicol (Copenh); 1979 Oct; 45(4):272-81. PubMed ID: 525358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian rhythms in catecholamines in organs of the golden hamster.
    Lew GM; Quay WB
    Am J Physiol; 1973 Mar; 224(3):503-8. PubMed ID: 4691261
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of guanethidine on contractile activity and ultrastructure of the myocardium in experimental studies].
    Drozdova GA; Kleĭmenova NN; Demurov EA; Frolov VA
    Kardiologiia; 1974 Oct; 14(10):60-4. PubMed ID: 4444117
    [No Abstract]   [Full Text] [Related]  

  • 38. Tissue catecholamine concentrations in the brain, heart and adrenals in experimental hypovolaemia in rats.
    Szymańska-Kosmala M; Filczewski M
    Acta Physiol Pol; 1980; 31(2):159-66. PubMed ID: 7395540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of DOPA administration on catecholamine metabolism in rats during physical exertion (swimming)].
    Matlina ESh; Zutler AS
    Probl Endokrinol (Mosk); 1973; 19(1):80-4. PubMed ID: 4698465
    [No Abstract]   [Full Text] [Related]  

  • 40. BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-beta-hydroxylase with antihypertensive activity.
    Claxton IM; Palfreyman MG; Poyser RH; Whiting RL
    Eur J Pharmacol; 1976 May; 37(1):179-88. PubMed ID: 1278239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.